1
|
Adorisio S, Muscari I, Fierabracci A, Thi Thuy T, Marchetti MC, Ayroldi E, Delfino DV. Biological effects of bergamot and its potential therapeutic use as an anti-inflammatory, antioxidant, and anticancer agent. Pharm Biol 2023; 61:639-646. [PMID: 37067190 PMCID: PMC10114982 DOI: 10.1080/13880209.2023.2197010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 02/22/2023] [Accepted: 03/25/2023] [Indexed: 06/19/2023]
Abstract
Context: Bergamot, mainly produced in the Ionian coastal areas of Southern Italy (Calabria), has been used since 1700 for its balsamic and medicinal properties. Phytochemical profiling has confirmed that bergamot juices are rich in flavonoids, including flavone and flavanone glycosides which are responsible for its beneficial effects.Objective: Recently, it was shown that the combination of natural compounds with conventional treatments improves the efficacy of anticancer therapies. Natural compounds with anticancer properties attack cancerous cells without being toxic to healthy cells. Bergamot can induce cytotoxic and apoptotic effects and prevent cell proliferation in various cancer cells.Methods: In this review, the antiproliferative, pro-apoptotic, anti-inflammatory, and antioxidant effects of bergamot are described. Information was compiled from databases such as PubMed, Web of Science, and Google Scholar using the key words 'bergamot' accompanied by 'inflammation' and, 'cancer' for data published from 2015-2021.Results: In vitro and in vivo studies provided evidence that different forms of bergamot (extract, juice, essential oil, and polyphenolic fraction) can affect several mechanisms that lead to anti-proliferative and pro-apoptotic effects that decrease cell growth, as well as anti-inflammatory and antioxidant effects.Conclusions: Considering the effects of bergamot and its new formulations, we affirm the importance of its rational use in humans and illustrate how bergamot can be utilized in clinical applications. Numerous studies evaluated the effect of new bergamot formulations that can affect the absorption and, therefore, the final effects by altering the therapeutic profile of bergamot and enhancing the scientific knowledge of bergamot.
Collapse
Affiliation(s)
| | - Isabella Muscari
- Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy
| | | | - Trinh Thi Thuy
- Institute of Chemistry, Vietnam Academy of Science and Technology Cau Giay, Graduate University of Science and Technology, Ha Noi, Vietnam
| | - Maria Cristina Marchetti
- Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy
| | - Emira Ayroldi
- Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy
| | | |
Collapse
|
2
|
Muscari I, Fierabracci A, Adorisio S, Moretti M, Cannarile L, Thi Minh Hong V, Ayroldi E, Delfino DV. Glucocorticoids and natural killer cells: A suppressive relationship. Biochem Pharmacol 2022; 198:114930. [PMID: 35149054 DOI: 10.1016/j.bcp.2022.114930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Revised: 01/11/2022] [Accepted: 01/13/2022] [Indexed: 11/02/2022]
Abstract
Glucocorticoids exert their pharmacological actions by mimicking and amplifying the function of the endogenous glucocorticoid system's canonical physiological stress response. They affect the immune system at the levels of inflammation and adaptive and innate immunity. These effects are the basis for therapeutic use of glucocorticoids. Innate immunity is the body's first line of defense against disease conditions. It is relatively nonspecific and, among its mediators, natural killer(NK) cells link innate and acquired immunity. NK cell numbers are altered in patients with auto immune diseases, and research suggests that interactions between glucocorticoids and natural killer cells arecritical for successful glucocorticoid therapy. The aim of this review is to summarize these interactions while highlighting the latest and most important developments in this field. Production and release in theblood of endogenous glucocorticoids are strictly regulated by the hypothalamus-pituitary-adrenal axis. Aself-regulatory mechanism prevents excessive plasma levels of these hormones. However, exogenousstimuli such as stress, inflammation, infections, cancer, and autoimmune disease can trigger thehypothalamus-pituitary-adrenal axis response and lead to excessive systemic release of glucocorticoids.Thus, stress stimuli, such as sleep deprivation, intense exercise, depression, viral infections, andcancer, can result in release of glucocorticoids and associated immunosuppressant effects. Among theseeffects are decreases in the numbers and activities of NK cells in inflammatory and autoimmune diseases(e.g., giant cell arteritis, polymyalgia rheumatica, and familial hypogammaglobulinemia).
Collapse
Affiliation(s)
- Isabella Muscari
- Section of Onco-hematology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Alessandra Fierabracci
- Immunology and Pharmacotherapy Research Area Bambino Gesù Children's Hospital, Rome, Italy
| | - Sabrina Adorisio
- Foligno Nursing School, Department of Medicine, University of Perugia, Foligno, PG, Italy
| | - Marina Moretti
- Section of Onco-hematology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Lorenza Cannarile
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | | | - Emira Ayroldi
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Domenico V Delfino
- Foligno Nursing School, Department of Medicine, University of Perugia, Foligno, PG, Italy; Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy.
| |
Collapse
|
3
|
Hridoy M, Gorapi MZH, Noor S, Chowdhury NS, Rahman MM, Muscari I, Masia F, Adorisio S, Delfino DV, Mazid MA. Putative Anticancer Compounds from Plant-Derived Endophytic Fungi: A Review. Molecules 2022; 27:296. [PMID: 35011527 PMCID: PMC8746379 DOI: 10.3390/molecules27010296] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 12/22/2021] [Accepted: 12/28/2021] [Indexed: 02/05/2023] Open
Abstract
Endophytic fungi are microorganisms that exist almost ubiquitously inside the various tissues of living plants where they act as an important reservoir of diverse bioactive compounds. Recently, endophytic fungi have drawn tremendous attention from researchers; their isolation, culture, purification, and characterization have revealed the presence of around 200 important and diverse compounds including anticancer agents, antibiotics, antifungals, antivirals, immunosuppressants, and antimycotics. Many of these anticancer compounds, such as paclitaxel, camptothecin, vinblastine, vincristine, podophyllotoxin, and their derivatives, are currently being used clinically for the treatment of various cancers (e.g., ovarian, breast, prostate, lung cancers, and leukemias). By increasing the yield of specific compounds with genetic engineering and other biotechnologies, endophytic fungi could be a promising, prolific source of anticancer drugs. In the future, compounds derived from endophytic fungi could increase treatment availability and cost effectiveness. This comprehensive review includes the putative anticancer compounds from plant-derived endophytic fungi discovered from 1990 to 2020 with their source endophytic fungi and host plants as well as their antitumor activity against various cell lines.
Collapse
Affiliation(s)
- Md. Hridoy
- Department of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh;
- Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
| | | | - Sadia Noor
- Department of Pharmacy, University of Asia Pacific, Dhaka 1215, Bangladesh; (M.Z.H.G.); (S.N.)
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| | | | | | - Isabella Muscari
- Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy; (I.M.); (F.M.)
| | - Francesco Masia
- Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy; (I.M.); (F.M.)
| | - Sabrina Adorisio
- Department of Medicine and Surgery, Foligno Nursing School and Section of Pharmacology, University of Perugia, Piazzale Severi, S. Andrea delle Fratte, 06129 Perugia, Italy;
| | - Domenico V. Delfino
- Department of Medicine and Surgery, Foligno Nursing School and Section of Pharmacology, University of Perugia, Piazzale Severi, S. Andrea delle Fratte, 06129 Perugia, Italy;
| | - Md. Abdul Mazid
- Department of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh;
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| |
Collapse
|
4
|
Cham BT, Linh NTT, Thao DT, Anh NTH, Tam NT, Anh BK, Muscari I, Adorisio S, Sung TV, Thuy TT, Delfino DV. Cell Growth Inhibition of Saponin XII from Dipsacus japonicus Miq. on Acute Myeloid Leukemia Cells. Molecules 2020; 25:molecules25153325. [PMID: 32707961 PMCID: PMC7435407 DOI: 10.3390/molecules25153325] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 07/17/2020] [Accepted: 07/19/2020] [Indexed: 11/30/2022] Open
Abstract
In previous studies, we isolated the known compound saponin XII from the roots of Dipsacus japonicus Miq. Here, we show that this compound reduced the number of acute myeloid leukemia OCI-AML3 cells as evaluated by a hemocytometer. Flow cytometry analyses demonstrated that the reported activity was associated with a significant increase of apoptosis and of cells in the G0/G1 phase of the cell cycle, with a decrease of cells in the S and G2/M phases. Thus, the inhibition of cell growth in OCI-AML3 cells was due to antiproliferative and pro-apoptotic effects. Interestingly, the bioactivity of saponin XII exerted its effect at a concentration as low as 1 µg/mL.
Collapse
Affiliation(s)
- Ba Thi Cham
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Nguyen Thi Thuy Linh
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Do Thi Thao
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Institute of Biotechnology, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam
| | - Nguyen Thi Hoang Anh
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Nguyen Thanh Tam
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Bui Kim Anh
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Isabella Muscari
- Section of onco-hematology, Department of Medicine, University of Perugia, 06132 Perugia, Italy;
| | - Sabrina Adorisio
- Foligno Nursing School, Department of Medicine, University of Perugia, 06132 Perugia, Italy;
| | - Tran Van Sung
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
| | - Trinh Thi Thuy
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.T.C.); (N.T.T.L.); (D.T.T.); (N.T.H.A.); (N.T.T.)
- Department of Natural Products Research, Institute of Chemistry, VAST, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi 100000, Vietnam; (B.K.A.); (T.V.S.)
- Correspondence: (T.T.T.); (D.V.D.); Tel.: +39-075-585-8328 (D.V.D.)
| | - Domenico V. Delfino
- Foligno Nursing School, Department of Medicine, University of Perugia, 06132 Perugia, Italy;
- Section of Pharmacology, Department of Medicine, University of Perugia, Piazzale Severi, S. Andrea delle Fratte, 06132 Perugia, Italy
- Correspondence: (T.T.T.); (D.V.D.); Tel.: +39-075-585-8328 (D.V.D.)
| |
Collapse
|
5
|
Muscari I, Adorisio S, Liberati AM, Thuy TT, Van Sung T, Cannarile L, Ayroldi E, Riccardi C, Delfino DV. Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes. J Transl Autoimmun 2020; 3:100035. [PMID: 32803151 PMCID: PMC7423577 DOI: 10.1016/j.jtauto.2020.100035] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Revised: 12/20/2019] [Accepted: 01/05/2020] [Indexed: 12/14/2022] Open
Abstract
Glucocorticoids promote thymocyte apoptosis and modulate transcription of numerous regulators of thymic apoptosis. Among these, glucocorticoid-induced leucine zipper (GILZ) is strongly upregulated in the thymus. We have previously demonstrated that GILZ decreases Bcl-xL expression, activates caspase-8 and caspase-3, and augments apoptosis in mice thymocytes. To better understand the causal links between glucocorticoids, GILZ, Bcl-xL, caspase-8, and caspase-3, we analyzed the thymocytes of Bcl-xL-overexpressing transgenic mice with or without glucocorticoid stimulation in vitro. Overexpression of Bcl-xL inhibited the glucocorticoid-induced up-regulation of GILZ in murine thymocytes as well as the glucocorticoid-dependent activation of caspase-8 and caspase-3. By contrast, no appreciable change in caspase-9 activation was observed upon Bcl-xL overexpression. Thus, these experiments highlighted a novel thymocyte apoptotic pathway in which Bcl-xL overexpression inhibited the glucocorticoid-induced activation of caspase-8 and caspase-3, but not caspase-9, as well as the accumulation of GILZ protein. These findings, together with our previous results showing that caspase-8 protects GILZ from proteasomal degradation, suggest the presence of a glucocorticoid-induced apoptosis self-amplification loop in which GILZ decreases Bcl-xL expression with a subsequent activation of caspase-8 and caspase-3; caspase-8 activation then enhances the stability and accumulation of GILZ and ensures the unimpeded and irreversible progression of apoptosis. By contrast, inappropriate increases in Bcl-xL levels could have catastrophic effects on thymic apoptosis as it would shut down caspase-8/3 activation, diminish the expression of GILZ, and impair the fine control necessary for thymic generation of a healthy immune repertoire. Bcl-xL is the main anti-apoptotic molecule of the BCl-2 family expressed in the thymus. Bcl-xL and GILZ are linked in a loop to influence each other’s expression. Overexpression of Bcl-xL inhibits GC-induced expression of Gilz, activation of caspase-8 and blocks thymocyte apoptosis.
Collapse
Affiliation(s)
- Isabella Muscari
- Department of Medicine, University of Perugia, Santa Maria Hospital, Terni, Italy
| | - Sabrina Adorisio
- Foligno Nursing School, Department of Medicine, University of Perugia, Foligno (PG), Italy
| | - Anna Marina Liberati
- Department of Medicine, University of Perugia, Santa Maria Hospital, Terni, Italy
| | - Trinh Thi Thuy
- Institute of Chemistry, Vietnam Academy of Science and Technology, Ha Noi, Viet Nam
| | - Tran Van Sung
- Institute of Chemistry, Vietnam Academy of Science and Technology, Ha Noi, Viet Nam
| | - Lorenza Cannarile
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Emira Ayroldi
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Carlo Riccardi
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Domenico V Delfino
- Foligno Nursing School, Department of Medicine, University of Perugia, Foligno (PG), Italy.,Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| |
Collapse
|
6
|
Adorisio S, Fierabracci A, Muscari I, Liberati AM, Calvitti M, Cossignani L, Blasi F, Quan TD, Tam NT, Sung TV, Riccardi C, Thuy TT, Delfino DV. Artocarpus tonkinensis Protects Mice Against Collagen-Induced Arthritis and Decreases Th17 Cell Function. Front Pharmacol 2019; 10:503. [PMID: 31214019 PMCID: PMC6554681 DOI: 10.3389/fphar.2019.00503] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Accepted: 04/23/2019] [Indexed: 12/25/2022] Open
Abstract
Artocarpus tonkinensis (Moraceae) is a tree that grows in north Vietnam whose leaf decoction is used as a traditional remedy by the Hmong ethnic group to treat arthritis and backache. Our study evaluated the decoction’s efficacy and mechanism of action in DBA/1J mice with collagen-induced arthritis (CIA). Mice treated with the decoction (At) either from the first collagen immunization or after CIA development experienced significantly less joint edema and inflammatory infiltration, whereas CIA-induced cartilage damage could only be prevented by early At treatment. Autoimmune gene expression profiles showed that Th17 cell-associated chemokine CCL20 and cytokines IL-6, IL-17, and IL-22 were strongly downregulated by At. Reduced expression of IL-2, IL-17, IL-22, and FasL in lymph node cells from At-treated mice was further confirmed by real-time PCR. The decoction also inhibited polarization of Th17 cells from CD4+ splenic T cells according to levels of IL-17 and RORC, a Th17 cell-specific transcription factor. Chromatographic analysis identified At’s major component as maesopsin-β-D-glucoside, which could inhibit in vitro differentiation of Th17 cells. The decoction significantly alleviated the signs and symptoms of CIA and inhibited the development and function of Th17 cells, highlighting its potent anti-inflammatory activity.
Collapse
Affiliation(s)
- Sabrina Adorisio
- Department of Medicine, Foligno Nursing School, University of Perugia, Foligno, Italy
| | - Alessandra Fierabracci
- Infectivology and Clinical Trials Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Isabella Muscari
- Section of Onco-hematology, Department of Medicine, Santa Maria Hospital, University of Perugia, Terni, Italy
| | - Anna Marina Liberati
- Section of Onco-hematology, Department of Medicine, Santa Maria Hospital, University of Perugia, Terni, Italy
| | - Mario Calvitti
- Department of Experimental Medicine, University of Perugia, Perugia, Italy
| | - Lina Cossignani
- Department of Pharmaceutical Sciences, Section of Food Science and Nutrition, University of Perugia, Perugia, Italy
| | - Francesca Blasi
- Department of Pharmaceutical Sciences, Section of Food Science and Nutrition, University of Perugia, Perugia, Italy
| | - Tran Duc Quan
- Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam
| | - Nguyen Thanh Tam
- Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam.,Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam
| | - Tran Van Sung
- Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam
| | - Carlo Riccardi
- Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| | - Trinh Thi Thuy
- Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam.,Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam
| | - Domenico V Delfino
- Department of Medicine, Foligno Nursing School, University of Perugia, Foligno, Italy.,Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italy
| |
Collapse
|
7
|
Adorisio S, Fierabracci A, Muscari I, Liberati AM, Ayroldi E, Migliorati G, Thuy TT, Riccardi C, Delfino DV. SUMO proteins: Guardians of immune system. J Autoimmun 2017; 84:21-28. [DOI: 10.1016/j.jaut.2017.09.001] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 09/04/2017] [Accepted: 09/04/2017] [Indexed: 12/11/2022]
|
8
|
Adorisio S, Fierabracci A, Gigliarelli G, Muscari I, Cannarile L, Liberati AM, Marcotullio MC, Riccardi C, Curini M, Robles Zepeda RE, Delfino DV. The Hexane Fraction of Bursera microphylla A. Gray Induces p21-Mediated Anti-Proliferative and Pro-Apoptotic Effects in Human Cancer-Derived Cell Lines. Integr Cancer Ther 2017; 17:138-147. [PMID: 29235378 PMCID: PMC5950952 DOI: 10.1177/1534735417696721] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Bursera microphylla (BM), one of the common elephant trees, is widely
distributed in the Sonoran Desert in Mexico. The Seri ethnic group in the Sonoran Desert
uses BM as an anti-inflammatory and painkiller drug for the treatment of sore throat,
herpes labialis, abscessed tooth, and wound healing. Dried stems and leaves of BM are used
in a tea to relieve painful urination and to stimulate bronchial secretion. Furthermore,
BM is used for fighting venereal diseases. To investigate the effects of the hexane
fraction of resin methanol extract (BM-H) on cell growth, the acute myeloid cell line
(OCI-AML3) was treated with 250, 25, or 2.5 µg/mL of BM-H. The first 2 concentrations were
able to significantly decrease OCI-AML3 cell number. This reduced cell number was
associated with decreased S-phase, blockade of the G2/M phase of the cell
cycle, and increased cell death. Similar results were obtained on all tested tumor cell
lines of different origins. We found that blockade of the cell cycle was due to
upregulation of p21 protein in a p53-independent way. Increase of p21 was possibly due to
upstream upregulation of p-ERK (which stabilizes p21 protein) and downregulation of p-38
(which promotes its degradation). Regarding cell death, activation of caspase-3, but not
of caspase-8 or -9, was detectable after BM-H treatment. In conclusion, these data suggest
that the BM’s hexane fraction inhibited proliferation of cell lines mainly by a
p21-dependent, p53-independent mechanism and promoted apoptosis through activation of
caspase-3, but not caspase-8 or -9.
Collapse
Affiliation(s)
- Sabrina Adorisio
- Section of Pharmacology, Department of
Medicine, University of Perugia, Perugia, Italy
| | - Alessandra Fierabracci
- Infettivology and Clinical Trials Area,
Bambino Gesù Children’s Hospital IRCCS, Rome, Italy
| | - Giulia Gigliarelli
- Department of Pharmaceutical Sciences,
University of Perugia, Perugia, Italy
| | - Isabella Muscari
- Section of Onco-hematology, S. Maria Terni
Hospital, Department of Surgery and Medical Sciences, University of Perugia, Perugia,
Italy
| | - Lorenza Cannarile
- Section of Pharmacology, Department of
Medicine, University of Perugia, Perugia, Italy
| | - Anna Marina Liberati
- Section of Onco-hematology, S. Maria Terni
Hospital, Department of Surgery and Medical Sciences, University of Perugia, Perugia,
Italy
| | | | - Carlo Riccardi
- Section of Pharmacology, Department of
Medicine, University of Perugia, Perugia, Italy
| | - Massimo Curini
- Department of Pharmaceutical Sciences,
University of Perugia, Perugia, Italy
| | | | - Domenico V. Delfino
- Section of Pharmacology, Department of
Medicine, University of Perugia, Perugia, Italy
- Foligno Nursing School, Department of
Medicine, University of Perugia, Perugia, Italy
- Domenico V. Delfino, Section of Pharmacology,
Foligno Nursing School, Department of Medicine, University of Perugia, Piazzale Severi, S.
Andrea delle Fratte, Perugia 06132, Italy.
| |
Collapse
|
9
|
Adorisio S, Fierabracci A, Gigliarelli G, Muscari I, Cannarile L, Liberati AM, Marcotullio MC, Riccardi C, Curini M, Robles Zepeda RE, Delfino DV. The Hexane Fraction of Bursera microphylla A Gray Induces p21-Mediated Antiproliferative and Proapoptotic Effects in Human Cancer-Derived Cell Lines. Integr Cancer Ther 2017; 16:426-435. [PMID: 28110563 PMCID: PMC5759934 DOI: 10.1177/1534735416688413] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Bursera microphylla (BM), one of the common elephant trees, is widely distributed in the Sonoran desert in Mexico. The Seri ethnic group in the Sonoran desert uses BM as an anti-inflammatory and painkiller drug for the treatment of sore throat, herpes labialis, abscessed tooth, and wound healing. Dried stems and leaves of BM are used in a tea to relieve painful urination and to stimulate bronchial secretion. Furthermore, BM is used for fighting venereal diseases. To investigate the effects of the hexane fraction of resin methanol extract (BM-H) on cell growth, the acute myeloid cell line (OCI-AML3) was treated with 250, 25, or 2.5 µg/mL of BM-H. The first 2 concentrations were able to significantly decrease OCI-AML3 cell number. This reduced cell number was associated with decreased S-phase, blockade of G2/M phase of the cell cycle, and increased cell death. Similar results were obtained on all tested tumor cell lines of different origins. We found that blockade of the cell cycle was a result of upregulation of p21 protein in a p53-independent way. Increase of p21 was possibly a result of upstream upregulation of p-ERK (which stabilizes p21 protein) and downregulation of p-38 (which promotes its degradation). Regarding cell death, activation of caspase-3, but not of caspase-8 or -9, was detectable after BM-H treatment. In conclusion, these data suggest that BM-H inhibited proliferation of cell lines mainly by a p21-dependent, p53-independent mechanism and promoted apoptosis through activation of caspase-3 but not caspase-8 or -9.
Collapse
Affiliation(s)
- Sabrina Adorisio
- 1 Section of Pharmacology, Department of Medicine, University of Perugia, Italy
| | - Alessandra Fierabracci
- 2 Infectivology and Clinical Trials Area, Bambino Gesù Children's Hospital IRCCS, Rome, Italy
| | | | - Isabella Muscari
- 4 Section of Onco-hematology, S. Maria Terni Hospital, Department of Surgery and Medical Sciences, University of Perugia, Italy
| | - Lorenza Cannarile
- 1 Section of Pharmacology, Department of Medicine, University of Perugia, Italy
| | - Anna Marina Liberati
- 4 Section of Onco-hematology, S. Maria Terni Hospital, Department of Surgery and Medical Sciences, University of Perugia, Italy
| | | | - Carlo Riccardi
- 1 Section of Pharmacology, Department of Medicine, University of Perugia, Italy
| | - Massimo Curini
- 3 Department of Pharmaceutical Sciences, University of Perugia, Italy
| | | | - Domenico V Delfino
- 1 Section of Pharmacology, Department of Medicine, University of Perugia, Italy.,6 Foligno Nursing School, Department of Medicine, University of Perugia, Italy
| |
Collapse
|
10
|
Adorisio S, Fierabracci A, Rossetto A, Muscari I, Nardicchi V, Liberati AM, Riccardi C, Van Sung T, Thuy TT, Delfino DV. Integration of Traditional and Western Medicine in Vietnamese Populations: A Review of Health Perceptions and Therapies. Nat Prod Commun 2016. [DOI: 10.1177/1934578x1601100949] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
In Vietnam, two types of traditional medicine (TM) are practiced: thuoc nam, medicine of the South, and thuoc bac, medicine of the North, both of which are largely based on herbal drugs used by different Vietnamese ethnic groups. This review presents recently published information from various databases regarding TM, especially herbal drugs, and its integration with Western medical practices outside and inside Vietnam. We first discuss the integration of traditional and modern health concepts by Vietnamese immigrants living outside Vietnam. Next, we describe native and emigrated health education and practices of pharmacy students, health professionals, and citizens living in Vietnam. Finally, we report the recent biological validation of medicinal plants and non-herbal therapies emerging from Vietnamese TM and their current and potential medical uses as identified by Western approaches. The main example described here involves utilization of the tree Artocarpus tonkinensis by the ethnic minority of Black Hmong in northern Vietnam, who use a decoction of its leaves to treat arthritis and backache without apparent adverse effects. Our comprehensive review emphasizes that, although Vietnam has a very rich collection of TM practices (particularly the use of herbal drugs), these therapies should be biologically and clinically validated with modern Western methods for optimal integration of Western and traditional medicine in global populations.
Collapse
Affiliation(s)
- Sabrina Adorisio
- Department of Pharmaceutical Sciences, Section of Public Health, University of Perugia, Via Fabretti 48, 06123, Perugia, Italy
| | - Alessandra Fierabracci
- Immunology and Pharmacotherapy Research Area Bambino Gesù Children's Hospital, Viale S. Paolo 15, 00146, Rome, Italy
| | - Ariele Rossetto
- Foligno Nursing School, Department of Medicine, University of Perugia, Via Oberdan 123, 06034, Foligno (PG), Italy
| | - Isabella Muscari
- Section of Onco-hematology, University of Perugia, Santa Maria Hospital, 05100, Terni, Italy
| | - Vincenza Nardicchi
- Clinical Urology and Andrology – Tissue Engineering Laboratory, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Severi, 06132, Perugia, Italy
| | - Anna Marina Liberati
- Section of Onco-hematology, University of Perugia, Santa Maria Hospital, 05100, Terni, Italy
| | - Carlo Riccardi
- Section of Pharmacology, Department of Medicine, University of Perugia, Piazzale Severi, 06132, Perugia, Italy
| | - Tran Van Sung
- Institute of Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
| | - Trinh Thy Thuy
- Institute of Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
| | - Domenico V. Delfino
- Section of Pharmacology, Department of Medicine, University of Perugia, Piazzale Severi, 06132, Perugia, Italy
| |
Collapse
|
11
|
Adorisio S, Fierabracci A, Rossetto A, Muscari I, Nardicchi V, Liberati AM, Riccardi C, Van Sung T, Thuy TT, Delfino DV. Integration of Traditional and Western Medicine in Vietnamese Populations: A Review of Health Perceptions and Therapies. Nat Prod Commun 2016; 11:1409-1416. [PMID: 30807048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Open
Abstract
In Vietnam, two types of traditional medicine (TM) are practiced: thuoc nam, medicine of the South, and thuoc bac, medicine of the North, both of which are largely based on herbal drugs used by different Vietnamese ethnic groups. This review presents recently published information from various databases regarding TM, especially herbal drugs, and its integration with Western medical practices outside and inside Vietnam. We first discuss the integration of traditional and modem health concepts by Vietnamese immigrants living outside Vietnam. Next, we describe native and emigrated health education and practices of pharmacy students, health professionals, and citizens living in Vietnam. Finally, we report the recent biological validation of medicinal plants and non-herbal therapies emerging from Vietnamese TM and their current and potential medical uses as identified by Western approaches. The main example described here involves utilization of the tree Artocarpus tonkinensis by the ethnic minority of Black Hmong in northern Vietnam, who use a decoction of its leaves to treat arthritis and backache without apparent adverse effects. Our comprehensive review emphasizes that, although Vietnam has a very rich collection of TM practices (particularly the use of herbal drugs), these therapies should be biologically and clinically validated with modem Western methods for optimal integration of Western and traditional medicine in global populations.
Collapse
|
12
|
Cantarini L, Lucherini OM, Vitale A, Sabadini L, Brizi MG, Frediani B, Muscari I, Galeazzi M. Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis. Intern Med J 2014; 43:725-7. [PMID: 23745996 DOI: 10.1111/imj.12163] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2012] [Accepted: 11/07/2012] [Indexed: 01/03/2023]
Abstract
Although idiopathic recurrent acute pericarditis (IRAP) is generally presumed to derive from an autoimmune process, increasing interest is currently being devoted to autoinflammatory diseases, a group of disorders of the innate immune system caused by mutations of genes involved in the regulation or activation of the inflammatory response, without any apparent involvement of autoimmunity. The tumour necrosis factor receptor-1-associated periodic syndrome is the most common autosomal dominant autoinflammatory disorder and is caused by mutations in the TNFRSF1A gene encoding the 55-kD receptor for tumour necrosis factor-α. IRAP patients carrying TNFRSF1A gene mutations have been recently described. We report herein the first IRAP patients carrying the rare R104Q and D12E TNFRSF1A gene mutations, thus expanding the spectrum of tumour necrosis factor receptor-1-associated periodic syndrome mutations in IRAP patients.
Collapse
Affiliation(s)
- L Cantarini
- Interdepartmental Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Unit of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Lucherini OM, Ferracin M, Fulci V, McDermott M, Merlini G, Muscari I, Magnotti F, Dickie LJ, Galeazzi M, Negrini M, Baldari CT, Obici L, Cimaz R, Cantarini L. PReS-FINAL-1010: circulating micrornas in traps. Pediatr Rheumatol Online J 2013. [PMCID: PMC4043651 DOI: 10.1186/1546-0096-11-s2-p8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
14
|
Durrant KL, Muscari I, Aróstegui JI. PW03-035 – Autoinflammatory diseases diagnostic chart/tool. Pediatr Rheumatol Online J 2013. [PMCID: PMC3952267 DOI: 10.1186/1546-0096-11-s1-a261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
15
|
Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G, Muscari I, Magnotti F, Dickie LJ, Galeazzi M, Negrini M, Baldari CT, Cimaz R, Cantarini L. OR10-004 - Circulating micrornas in TRAPS. Pediatr Rheumatol Online J 2013. [PMCID: PMC3952357 DOI: 10.1186/1546-0096-11-s1-a187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
16
|
Caso F, Cantarini L, Lucherini OM, Sfriso P, Fioretti M, Costa L, Vitale A, Atteno M, Galeazzi M, Muscari I, Magnotti F, Frediani B, Punzi L, Rigante D. Working the endless puzzle of hereditary autoinflammatory disorders. Mod Rheumatol 2013; 24:381-9. [PMID: 24251993 DOI: 10.3109/14397595.2013.843755] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Hereditary autoinflammatory disorders encompass manifold dysfunctions of innate immunity caused by mutations in genes coding for the main characters of the inflammatory scene: most of these conditions have an early onset, ranging from the first days of life to the first decades, and include hereditary periodic fevers, NLRP-related diseases, granulomatous and pyogenic syndromes, which are basically characterized by upturned inflammasome activity and overproduction of bioactive interleukin (IL)-1β and other proinflammatory cytokines. The discovery of a causative link between autoinflammation and IL-1β release has improved our understanding of the intimate mechanisms of innate immunity, and has likewise led to the identification of extraordinary treatments for many of these disorders.
Collapse
Affiliation(s)
- Francesco Caso
- Rheumatology Unit, Department of Medicine, University of Padua , Padua , Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G, Muscari I, Magnotti F, Dickie LJ, Galeazzi M, Negrini M, Baldari CT, Cimaz R, Cantarini L. First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 2013; 8:e73443. [PMID: 24066048 PMCID: PMC3774691 DOI: 10.1371/journal.pone.0073443] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2013] [Accepted: 07/20/2013] [Indexed: 01/08/2023] Open
Abstract
Tumor necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant autoinflammatory disorder characterized by recurrent episodes of long-lasting fever and inflammation in different regions of the body, such as the musculo-skeletal system, skin, gastrointestinal tract, serosal membranes and eye. Our aims were to evaluate circulating microRNAs (miRNAs) levels in patients with TRAPS, in comparison to controls without inflammatory diseases, and to correlate their levels with parameters of disease activity and/or disease severity. Expression levels of circulating miRNAs were measured by Agilent microarrays in 29 serum samples from 15 TRAPS patients carrying mutations known to be associated with high disease penetrance and from 8 controls without inflammatory diseases. Differentially expressed and clinically relevant miRNAs were detected using GeneSpring GX software. We identified a 6 miRNAs signature able to discriminate TRAPS from controls. Moreover, 4 miRNAs were differentially expressed between patients treated with the interleukin (IL)-1 receptor antagonist, anakinra, and untreated patients. Of these, miR-92a-3p and miR-150-3p expression was found to be significantly reduced in untreated patients, while their expression levels were similar to controls in samples obtained during anakinra treatment. MiR-92b levels were inversely correlated with the number of fever attacks/year during the 1st year from the index attack of TRAPS, while miR-377-5p levels were positively correlated with serum amyloid A (SAA) circulating levels. Our data suggest that serum miRNA levels show a baseline pattern in TRAPS, and may serve as potential markers of response to therapeutic intervention.
Collapse
Affiliation(s)
- Orso Maria Lucherini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy
| | - Laura Obici
- Amyloid Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
| | - Manuela Ferracin
- Department of Morphology, Surgery and Experimental Medicine, Pathology Section and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy
| | - Valerio Fulci
- Dipartimento di Biotecnologie Cellulari ed Ematologia, Sezione di Genetica Molecolare, Sapienza Università di Roma, Rome, Italy
| | - Michael F. McDermott
- NIHR-Leeds Musculoskeletal Biomedical Research Unit (NIHR-LMBRU), Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, United Kingdom
| | - Giampaolo Merlini
- Amyloid Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
| | - Isabella Muscari
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy
| | - Flora Magnotti
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy
| | - Laura J. Dickie
- NIHR-Leeds Musculoskeletal Biomedical Research Unit (NIHR-LMBRU), Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, United Kingdom
| | - Mauro Galeazzi
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy
| | - Massimo Negrini
- Department of Morphology, Surgery and Experimental Medicine, Pathology Section and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy
| | | | - Rolando Cimaz
- Department of Pediatrics, Rheumatology Unit, Anna Meyer Children’s Hospital and University of Florence, Florence, Italy
| | - Luca Cantarini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy
- * E-mail:
| |
Collapse
|
18
|
Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F, Brizi MG, Guerrini S, Patti M, Punzi L, Galeazzi M, Cantarini L. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm 2013; 2013:939847. [PMID: 23970817 PMCID: PMC3736401 DOI: 10.1155/2013/939847] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2013] [Accepted: 05/27/2013] [Indexed: 01/18/2023] Open
Abstract
Treatment of monogenic autoinflammatory disorders, an expanding group of hereditary diseases characterized by apparently unprovoked recurrent episodes of inflammation, without high-titre autoantibodies or antigen-specific T cells, has been revolutionized by the discovery that several of these conditions are caused by mutations in proteins involved in the mechanisms of innate immune response, including components of the inflammasome, cytokine receptors, receptor antagonists, and oversecretion of a network of proinflammatory molecules. Aim of this review is to synthesize the current experience and the most recent evidences about the therapeutic approach with biologic drugs in pediatric and adult patients with monogenic autoinflammatory disorders.
Collapse
Affiliation(s)
- Antonio Vitale
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Donato Rigante
- Institute of Pediatrics, Università Cattolica Sacro Cuore, Policlinico A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy
| | - Orso Maria Lucherini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Francesco Caso
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
| | - Isabella Muscari
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Flora Magnotti
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Maria Giuseppina Brizi
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Susanna Guerrini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Maria Patti
- Institute of Pediatrics, Università Cattolica Sacro Cuore, Policlinico A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy
| | - Leonardo Punzi
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
| | - Mauro Galeazzi
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| | - Luca Cantarini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
| |
Collapse
|
19
|
Cantarini L, Vitale A, Lucherini OM, Muscari I, Magnotti F, Brizi G, Frediani B, Sebastiani GD, Galeazzi M, Rigante D. Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined. Reumatismo 2013; 65:55-62. [PMID: 23877409 DOI: 10.4081/reumatismo.2013.55] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2013] [Revised: 05/13/2013] [Accepted: 05/31/2013] [Indexed: 11/22/2022] Open
Abstract
Autoinflammatory disorders are characterized by spontaneous episodes of systemic inflammation deriving from inherited defects of the innate immune system. Childhood is usually the lifetime involved in most inherited autoinflammatory disorders, but a moderate number of patients may experience disease onset during adulthood. Herein we report our experience in the clinical and genetic approach to the diagnosis of autoinflammatory disorders in regard of the first 500 pediatric and adult patients evaluated during the period 2007-2012 in our Center, due to histories of periodically-recurring inflammatory attacks, giving emphasis to the differences observed according to patients'age and to the most relevant data differentiating child and adult-onset autoinflammatory disorders in the medical literature.
Collapse
Affiliation(s)
- L Cantarini
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Unit of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Balistreri E, Bugatti S, Cervone R, Sebastiani G, Giannitti C, Muscari I, Caporali R, Selvi E, Montecucco C, Galeazzi M. AB0012 Microrna-223 in synovial tissue of rheumatoid arthritis and osteoarthritis patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
21
|
Galeazzi M, Obici L, Ferracin M, Fulci V, McDermott MF, Lucherini OM, Merlini G, Dickie L, Muscari I, Frediani B, Negrini M, Cimaz R, Cantarini L. OP0074 First Report of Circulating Micrornas in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS). Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
22
|
Muscari I, Giannitti C, Niccolini S, Fineschi I, Sebastiani G, Prevete I, Iuliano A, Balistreri E, Gennai I, Minisola G, Spreafico A, Galeazzi M. THU0011 MIR-223 expression in serum and CD3+ peripheral cells of rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.1976] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
23
|
Magnotti F, Vitale A, Rigante D, Lucherini OM, Cimaz R, Muscari I, Granados Afonso de Faria A, Frediani B, Galeazzi M, Cantarini L. The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. Clin Exp Rheumatol 2013; 31:141-149. [PMID: 23899820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2013] [Accepted: 04/09/2013] [Indexed: 06/02/2023]
Abstract
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant autoinflammatory disorder characterised by recurrent episodes of long-lasting fever and inflammation in different regions of the body, as musculo-skeletal system, skin, gastrointestinal tube, serosal membranes and eye. Inflammatory attacks usually start in the pediatric age with initial corticosteroid-responsiveness. Most reported cases of TRAPS involve patients of European ancestry and diagnosis can be formulated by the combination of genetic analysis and a compatible phenotype. Its prognosis is strictly dependent on the appearance of amyloidosis, secondary to uncontrolled relapsing inflammation. Thanks to a better understanding of its pathogenesis, the disease is now managed with anti-interleukin (IL)-1 antagonists, rather than corticosteroids or tumour necrosis factor (TNF) inhibitors. The aim of this review is to describe the current understanding and advances of TRAPS genetic basis, pathogenesis and management options by integrating the most recent data in the medical literature.
Collapse
Affiliation(s)
- Flora Magnotti
- Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Cantarini L, Brucato A, Simonini G, Imazio M, Cumetti D, Cimaz R, Bacarelli MR, Muscari I, Vitale A, Lucherini OM, Galeazzi M, Fioravanti A. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report. Clin Exp Rheumatol 2013; 31:207-212. [PMID: 23137677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Accepted: 06/13/2012] [Indexed: 06/01/2023]
Abstract
OBJECTIVES Idiopathic recurrent acute pericarditis (IRAP) represents the most troublesome complication of acute pericarditis and is an autoimmune process. White adipose tissue produces more than 50 adipokines that participate in inflammation and autoimmunity. This study investigated whether serum leptin, resistin, visfatin and adiponectin are increased in IRAP versus healthy controls and if their levels correlate with parameters of disease activity. METHODS Serum leptin, resistin, visfatin and adiponectin levels were assayed by enzyme-linked immunosorbent assay in 14 IRAP patients during recurrences (group 1), in 23 IRAP patients during symptom-free intervals (group 2) and in 18 healthy controls (group 3). Assessment parameters included demographic characteristics of patients and controls, clinical characteristics of patients and markers of inflammation. Comparisons between groups as well as reciprocal comparisons were evaluated. RESULTS Group 1 showed serum leptin (p<0.008), visfatin (p<0.002), and adiponectin (p<0.04) significantly higher than group 2 and control group, whereas resistin serum levels did not significantly differ (p=0.69). Among IRAP patients, serum leptin significantly correlated with serum amyloid A (SAA) levels (rs=0.43, r2= 0.27, p<0.02). Other than this correlation, none of the considered adipokines significantly correlated with the other considered variables in univariate analysis. CONCLUSIONS Leptin, adiponectin and visfatin are increased in IRAP patients versus healthy controls. Our data suggest that these adipokines might be involved in IRAP pathogenesis and that a possible increased cardiovascular risk in these patients, through an early onset atherosclerosis, should be kept in mind. SAA might be a link between IRAP and increased cardiovascular diseases.
Collapse
|
25
|
Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives. Autoimmun Rev 2012; 12:38-43. [DOI: 10.1016/j.autrev.2012.07.020] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|